Osteoporosis

Latest News

Evaluating Bone Microarchitecture and Strength in Women With HIV

By

Amit Akirov, MD

Bone microarchitecture and strength are reduced in women living with HIV, and tenofovir treatment may contribute to bone deficits.

Inhibition of Sclerostin May Increase Cardiovascular Risk

Inhibition of sclerostin with romosozumab may increase cardiovascular risk.

Safety and Efficacy of Romosozumab Demonstrated in Postmenopausal Women With Mild to Moderate CKD

By

Morgan E. Meissner

The safety and efficacy of romosozumab for osteoporosis treatment in postmenopausal women are not significantly affected by reduced kidney function.

Hand Osteoarthritis Associated With Changes in Bone Architecture and Strength

By

Morgan E. Meissner

Researchers assessed the impact of primary hand osteoarthritis on bone mass, microstructure, and biomechanics in the affected skeletal regions.

Low Physical Function, Lean Body Mass Predict Accelerated Bone Loss After Hip Fracture

By

Amit Akirov, MD

Lower physical function and lean body mass are associated with increased risk for accelerated bone loss in older patients with previous hip fracture.

Abaloparatide Effective for Younger Postmenopausal Women at High Fracture Risk

By

Rose Reeb

Abaloparatide treatment significantly increases bone mineral density in younger postmenopausal women at high risk for fracture.

Osteoporotic Fracture Risk Lower With DOACs Than Warfarin in Atrial Fibrillation

For patients with atrial fibrillation, the risk for osteoporotic fracture appears to be lower with direct oral anticoagulant use compared with warfarin use.

High-Density Lipoprotein May Be a Predictor of Osteoporosis in Rheumatoid Arthritis

By

Morgan E. Meissner

Researchers explored the clinical significance of high density lipoprotein in patients with and without osteoporosis with rheumatoid arthritis.

Updated AACE/ACE Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis: What Do Clinicians Need to Know?

By

Morgan E. Meissner

The ACE and AACE released a 2020 update to their clinical practice guidelines for the treatment and diagnosis of postmenopausal osteoporosis.

Dairy Intake Not Found to Affect BMD During Menopausal Transition

By

Rose Reeb

Level of dairy intake does not affect the rate of bone mineral density loss or fracture risk among perimenopausal women.

Measuring Bone Characteristics and Derangement in Patients With Adrenal Incidentaloma

By

Amit Akirov, MD

High-resolution peripheral quantitative computed tomography can be used to assess bone abnormalities in patients with adrenal incidentaloma.